Cargando…

Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus

INTRODUCTION: The risk of cardiovascular disease (CVD) and atherosclerosis is reported to be increased in systemic lupus erythematosus (SLE). We recently reported a negative association between natural IgM-antibodies against phosphorylcholine (anti-PC) in the general population, high anti-PC levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anania, Cristina, Gustafsson, Thomas, Hua, Xiang, Su, Jun, Vikström, Max, de Faire, Ulf, Heimbürger, Mikael, Jogestrand, Tomas, Frostegård, Johan
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046524/ https://www.ncbi.nlm.nih.gov/pubmed/21092251 http://dx.doi.org/10.1186/ar3193

Ejemplares similares

Antibodies against Native and Oxidized Cardiolipin and Phosphatidylserine and Phosphorylcholine in Atherosclerosis Development
por: Frostegård, Anna G., et al.
Publicado: (2014)

IgM-Antibodies against Phosphorylcholine in Mothers and Normal or Low Birth Weight Term Newborn Infants
por: Frostegård, Anna G., et al.
Publicado: (2014)

Immunoglobulin G1 Antibodies Against Phosphorylcholine Are Associated With Protection in Systemic Lupus Erythematosus and Atherosclerosis: Potential Underlying Mechanisms
por: Thiagarajan, D., et al.
Publicado: (2020)

IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases
por: Thiagarajan, Divya, et al.
Publicado: (2020)

Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study
por: Ajeganova, Sofia, et al.
Publicado: (2015)

Antibodies Against Phosphorylcholine Among 60-Year-Olds: Clinical Role and Simulated Interactions
por: Samal, Shailesh Kumar, et al.
Publicado: (2022)

IgM antibodies to oxidized phosphatidylserine as protection markers in cardiovascular disease among 60-year olds
por: Frostegård, Johan, et al.
Publicado: (2017)

Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New Guinea
por: Frostegård, Johan, et al.
Publicado: (2007)

Low levels of IgM antibodies to oxidized cardiolipin increase and high levels decrease risk of cardiovascular disease among 60-year olds: a prospective study
por: Su, Jun, et al.
Publicado: (2013)

Human IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60‐Year‐Olds
por: Thiagarajan, Divya, et al.
Publicado: (2016)

Atherosclerotic plaque vulnerability is increased in mouse model of lupus
por: Santiago-Raber, Marie-Laure, et al.
Publicado: (2020)

Antibodies against Phosphorylcholine—Implications for Chronic Inflammatory Diseases
por: Frostegård, Johan
Publicado: (2023)

IgG, IgM, and IgA Antinuclear Antibodies in Discoid and Systemic Lupus Erythematosus Patients
por: Jost, Sheridan A., et al.
Publicado: (2014)

IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome
por: Knudsen, Eva Cecilie, et al.
Publicado: (2019)

IgM Repertoire Biodiversity is Reduced in HIV-1 Infection and Systemic Lupus Erythematosus
por: Yin, Li, et al.
Publicado: (2013)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Systemic lupus erythematosus and cardiovascular disease
por: Frostegård, Johan
Publicado: (2022)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

Ultrasound Tissue Characterization of Vulnerable Atherosclerotic Plaque
por: Picano, Eugenio, et al.
Publicado: (2015)

Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques
por: Lee, Soo Jin, et al.
Publicado: (2015)

Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives
por: Stefanadis, Christodoulos, et al.
Publicado: (2017)

Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques
por: Mangge, Harald, et al.
Publicado: (2019)

Calcification in Atherosclerotic Plaque Vulnerability: Friend or Foe?
por: Shi, Xuan, et al.
Publicado: (2020)

Colchicine reduces atherosclerotic plaque vulnerability in rabbits
por: Roubille, François, et al.
Publicado: (2021)

Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?
por: Chiorescu, Roxana Mihaela, et al.
Publicado: (2022)

Correlation Between Calcification Characteristics of Carotid Atherosclerotic Plaque and Plaque Vulnerability
por: Xu, Xiangli, et al.
Publicado: (2021)

Antibodies against malondialdehyde among 60-year-olds: prediction of cardiovascular disease
por: Samal, Shailesh Kumar, et al.
Publicado: (2023)

Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases
por: de Vries, M. R., et al.
Publicado: (2021)

Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models
por: Gargiulo, Sara, et al.
Publicado: (2016)

BIRC6 Is Associated with Vulnerability of Carotid Atherosclerotic Plaque
por: Alloza, Iraide, et al.
Publicado: (2020)

Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality
por: Samal, S. K., et al.
Publicado: (2020)

Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients
por: López, Patricia, et al.
Publicado: (2016)

False-positive dengue IgM test result in a patient with systemic lupus erythematosus: a case report
por: Kamolratanakul, Supitcha, et al.
Publicado: (2020)

Low Levels of IgM and IgA Recognizing Acetylated C1-Inhibitor Peptides Are Associated with Systemic Lupus Erythematosus in Taiwanese Women
por: Tsai, Kai-Leun, et al.
Publicado: (2019)

IgG and IgM autoantibody differences in discoid and systemic lupus patients
por: Chong, Benjamin F., et al.
Publicado: (2012)

Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability
por: Hutcheson, Joshua D., et al.
Publicado: (2014)

The role of near-infrared spectroscopy in the detection of vulnerable atherosclerotic plaques
por: Horvath, Martin, et al.
Publicado: (2016)

Lectin Pathway of Complement Activation Is Associated with Vulnerability of Atherosclerotic Plaques
por: Fumagalli, Stefano, et al.
Publicado: (2017)

Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque
por: Wang, Xueyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ibenv1qi5o23779pdvc0vsgig0